In hormone receptor-positive breast cancer, RAB25 expression is a poor prognosis factor, whereas the breast cancer subtype with the worst prognosis, triple negative for hormonal receptors presents loss of RAB25 expression [18, 42]. This evidence concerns the gene RAB25 and breast cancer.